Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

INDUSTRY × Hearing Loss × ebselen × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1

Conditions

Hearing Loss 2 Tinnitus 1 Ototoxicity 1 Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Deafness 1

Interventions

sodium thiosulfate 2 ebselen 2 Sodium Chloride 1 Hyaluronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01451853 2017-09-25

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Sound Pharmaceuticals, Incorporated

Phase 2 Unknown

Head & NeckThoracic

Ototoxicity, Deafness, Head and Neck Neoplasms, Lung Neoplasms, Tinnitus, Hearing Loss

NCT01452607 2016-06-29

Study to Evaluate the Safety and Pharmacokinetics of SPI-1005

Sound Pharmaceuticals, Incorporated

Phase 1 Completed

Neoplasms, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡